What companies are GERN's competitors?

Geron Corporation (GERN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GERN compare to its peers?

The peer comparison table on this page shows Geron Corporation (GERN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GERN operate in?

Geron Corporation (GERN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

GERN

Geron Corporation

NASDAQ·Biotechnology · Healthcare

$1.12$0.01−0.88%

Market cap$719.57M·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About GERN

What companies are GERN's competitors?: Geron Corporation (GERN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GERN compare to its peers?: The peer comparison table on this page shows Geron Corporation (GERN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GERN operate in?: Geron Corporation (GERN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

GERN

Geron Corporation

NASDAQ·Biotechnology · Healthcare

$1.12$0.01−0.88%

Market cap$719.57M·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


INCYINCYIncyte Corporation	Incyte Corporation	$115.71	$23.5B
SLSSLSSELLAS Life Sciences Group, Inc.	SELLAS Life Sciences Group, Inc.	$11.54	$2.3B
COAGCOAGHemab Therapeutics Holdings, Inc. Common Stock	Hemab Therapeutics Holdings, Inc. Common Stock	$34.40	$1.6B
DMRADMRADamora Therapeutics, Inc.	Damora Therapeutics, Inc.	$21.09	$1.3B
RIGLRIGLRigel Pharmaceuticals, Inc.	Rigel Pharmaceuticals, Inc.	$48.13	$899.1M
IPSCIPSCCentury Therapeutics, Inc.	Century Therapeutics, Inc.	$1.46	$264.4M
ATNMATNMActinium Pharmaceuticals, Inc.	Actinium Pharmaceuticals, Inc.	$1.52	$47.8M

Frequently Asked Questions About GERN

What companies are GERN's competitors?: Geron Corporation (GERN)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GERN compare to its peers?: The peer comparison table on this page shows Geron Corporation (GERN) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GERN operate in?: Geron Corporation (GERN) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.